PMID- 17006666 OWN - NLM STAT- MEDLINE DCOM- 20070918 LR - 20211203 IS - 0012-186X (Print) IS - 0012-186X (Linking) VI - 49 IP - 12 DP - 2006 Dec TI - Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. PG - 3049-57 AB - AIMS/HYPOTHESIS: Activation of nutrient sensing through mammalian target of rapamycin (mTOR) has been linked to the pathogenesis of insulin resistance. We examined activation of mTOR-signalling in relation to insulin resistance and hepatic steatosis in mice. MATERIALS AND METHODS: Chronic hepatic steatosis and hepatic insulin resistance were induced by high-fat feeding of male C57BL/6Jico mice for 6 weeks. In addition, acute hepatic steatosis in the absence of insulin resistance was induced by pharmacological blockade of beta-oxidation using tetradecylglycidic acid (TDGA). mTOR signalling was examined in liver homogenates. RESULTS: High-fat feeding caused obesity (p<0.001), hepatic steatosis (p<0.05) and hepatic insulin resistance (p<0.05). The phosphorylation of mTOR and its downstream targets p70S6 kinase and S6 ribosomal protein was two-fold higher in mice on a high-fat diet than in mice fed standard chow (all p<0.05) and associated with enhanced rates of protein synthesis. Acute induction of hepatic steatosis with TDGA had no effect on mTOR activity. The increased activity of the mTOR pathway in livers from mice on a high-fat diet could not be ascribed to diet-induced alterations in known modulators of mTOR activity such as circulating plasma leucine levels, phosphorylation of protein kinase B and AMP-activated protein kinase, and changes in mitochondrial function. CONCLUSIONS/INTERPRETATION: High-fat diet induces increase of the mTOR nutrient sensing pathway in association with hepatic insulin resistance, but not with hepatic lipid accumulation as such. FAU - Korsheninnikova, E AU - Korsheninnikova E AD - Department of Molecular Cell Biology, Leiden University Medical Centre, Postzone S1-P, Postbus 9600, 2300 RC, Leiden, The Netherlands. Elena@lumc.nl FAU - van der Zon, G C M AU - van der Zon GC FAU - Voshol, P J AU - Voshol PJ FAU - Janssen, G M AU - Janssen GM FAU - Havekes, L M AU - Havekes LM FAU - Grefhorst, A AU - Grefhorst A FAU - Kuipers, F AU - Kuipers F FAU - Reijngoud, D-J AU - Reijngoud DJ FAU - Romijn, J A AU - Romijn JA FAU - Ouwens, D M AU - Ouwens DM FAU - Maassen, J A AU - Maassen JA LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060928 PL - Germany TA - Diabetologia JT - Diabetologia JID - 0006777 RN - 0 (Blood Glucose) RN - 0 (DNA, Mitochondrial) RN - 0 (Dietary Fats) RN - 0 (Fatty Acids) RN - 0 (Insulin) RN - 0 (Ribosomal Proteins) RN - EC 1.9.3.1 (Electron Transport Complex IV) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - GMW67QNF9C (Leucine) SB - IM MH - Animals MH - Blood Glucose/metabolism MH - DNA, Mitochondrial/genetics MH - Dietary Fats MH - Electron Transport Complex IV/genetics/metabolism MH - Fatty Acids/metabolism MH - Fatty Liver/*physiopathology MH - Insulin/blood MH - *Insulin Resistance MH - Leucine/blood MH - Liver/*physiology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Phosphatidylinositol 3-Kinases/metabolism MH - Phosphorylation MH - Protein Kinases/*physiology MH - Ribosomal Proteins/genetics MH - TOR Serine-Threonine Kinases EDAT- 2006/09/29 09:00 MHDA- 2007/09/19 09:00 CRDT- 2006/09/29 09:00 PHST- 2006/05/10 00:00 [received] PHST- 2006/07/24 00:00 [accepted] PHST- 2006/09/29 09:00 [pubmed] PHST- 2007/09/19 09:00 [medline] PHST- 2006/09/29 09:00 [entrez] AID - 10.1007/s00125-006-0439-5 [doi] PST - ppublish SO - Diabetologia. 2006 Dec;49(12):3049-57. doi: 10.1007/s00125-006-0439-5. Epub 2006 Sep 28.